Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Publications section now includes a note that items are automatically filled from PubMed. The revision tag updates from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T13:42:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The government funding lapse notice has been removed from the page, and this does not affect the study details or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:20:18.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Substantive study details (eligibility criteria, interventions, primary/secondary outcomes, and locations) appear unchanged. Minor formatting differences observed do not affect the content.
    Difference
    0.4%
    Check dated 2025-10-27T20:50:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    2%
    Check dated 2025-10-06T07:56:21.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.0%
    Check dated 2025-09-29T04:25:38.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Updated the page revision to v3.0.2 from v3.0.1 and removed the 'Back to Top' element. No core content, pricing, or availability changes.
    Difference
    0.1%
    Check dated 2025-09-14T21:52:24.000Z thumbnail image

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.